Hematology TimesFDA to rely on foreign authorities’ inspectionsNovember 1, 2017PharmacyRelated Issues
Hematology TimesFDA approves IV formulation of drug for CINVOctober 27, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Hematology TimesHemophilia B therapy approved in Saudi ArabiaOctober 27, 2017ThrombosisPharmacyBleeding Disorders
Hematology TimesCHMP recommends new formulation of pegaspargaseOctober 15, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesJapan approves product for hemophilia ASeptember 30, 2017ThrombosisPharmacyBleeding Disorders
Hematology TimesDaratumumab combos approved to treat MM in JapanSeptember 28, 2017Multiple MyelomaPharmacy
Hematology TimesSCD drug receives rare pediatric disease designationSeptember 22, 2017AnemiaPediatricsPharmacy
Hematology TimesMidostaurin approved to treat AML, SM in EuropeSeptember 21, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesCHMP recommends approval of generic imatinibSeptember 18, 2017CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
Hematology TimesCHMP advocates refusal of application for SM drugSeptember 18, 2017Leukemia, Myelodysplasia, TransplantationPharmacy
Hematology TimesApplication for pegfilgrastim biosimilar withdrawnSeptember 17, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology TimesCHMP recommends approval of nilotinib for kidsSeptember 16, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
